nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—SLC15A2—melanoma	0.665	0.83	CbGaD
Perindopril—ABCB1—melanoma	0.137	0.17	CbGaD
Perindopril—ACE—umbilical vein—melanoma	0.00492	0.144	CbGeAlD
Perindopril—ACE—hindlimb—melanoma	0.00451	0.132	CbGeAlD
Perindopril—ACE—arm—melanoma	0.0043	0.126	CbGeAlD
Perindopril—ACE—appendage—melanoma	0.00387	0.113	CbGeAlD
Perindopril—ACE—endothelium—melanoma	0.00233	0.0684	CbGeAlD
Perindopril—ACE—blood vessel—melanoma	0.00215	0.0631	CbGeAlD
Perindopril—ACE—neck—melanoma	0.00154	0.0451	CbGeAlD
Perindopril—SLC15A1—mammalian vulva—melanoma	0.00127	0.0372	CbGeAlD
Perindopril—Spirapril—SLC15A2—melanoma	0.00124	0.173	CrCbGaD
Perindopril—Moexipril—SLC15A2—melanoma	0.00119	0.166	CrCbGaD
Perindopril—ACE—eye—melanoma	0.00114	0.0336	CbGeAlD
Perindopril—Cilazapril—SLC15A2—melanoma	0.00111	0.154	CrCbGaD
Perindopril—Quinapril—SLC15A2—melanoma	0.00111	0.154	CrCbGaD
Perindopril—Ramipril—SLC15A2—melanoma	0.00107	0.149	CrCbGaD
Perindopril—Trandolapril—SLC15A2—melanoma	0.00107	0.149	CrCbGaD
Perindopril—SLC15A2—retina—melanoma	0.000989	0.029	CbGeAlD
Perindopril—ACE—mammalian vulva—melanoma	0.000908	0.0266	CbGeAlD
Perindopril—ABCB1—blood vessel—melanoma	0.000757	0.0222	CbGeAlD
Perindopril—BCHE—skin of body—melanoma	0.000736	0.0216	CbGeAlD
Perindopril—BCHE—mammalian vulva—melanoma	0.000671	0.0197	CbGeAlD
Perindopril—ACE—head—melanoma	0.00065	0.0191	CbGeAlD
Perindopril—SLC15A2—head—melanoma	0.000567	0.0166	CbGeAlD
Perindopril—BCHE—head—melanoma	0.00048	0.0141	CbGeAlD
Perindopril—ACE—lymph node—melanoma	0.000455	0.0133	CbGeAlD
Perindopril—ABCB1—retina—melanoma	0.000399	0.0117	CbGeAlD
Perindopril—SLC15A2—lymph node—melanoma	0.000397	0.0116	CbGeAlD
Perindopril—BCHE—lymph node—melanoma	0.000336	0.00986	CbGeAlD
Perindopril—ABCB1—mammalian vulva—melanoma	0.00032	0.00938	CbGeAlD
Perindopril—Erythema multiforme—Temozolomide—melanoma	0.000319	0.00238	CcSEcCtD
Perindopril—Eye disorder—Temozolomide—melanoma	0.000315	0.00235	CcSEcCtD
Perindopril—Tinnitus—Temozolomide—melanoma	0.000315	0.00234	CcSEcCtD
Perindopril—Malaise—Bleomycin—melanoma	0.000314	0.00234	CcSEcCtD
Perindopril—Cardiac disorder—Temozolomide—melanoma	0.000313	0.00233	CcSEcCtD
Perindopril—Flushing—Temozolomide—melanoma	0.000313	0.00233	CcSEcCtD
Perindopril—Arrhythmia—Carmustine—melanoma	0.000312	0.00232	CcSEcCtD
Perindopril—Leukopenia—Bleomycin—melanoma	0.000312	0.00232	CcSEcCtD
Perindopril—Dizziness—Vemurafenib—melanoma	0.00031	0.00231	CcSEcCtD
Perindopril—Alopecia—Carmustine—melanoma	0.000309	0.0023	CcSEcCtD
Perindopril—Angiopathy—Temozolomide—melanoma	0.000306	0.00228	CcSEcCtD
Perindopril—Mental disorder—Carmustine—melanoma	0.000306	0.00228	CcSEcCtD
Perindopril—Mediastinal disorder—Temozolomide—melanoma	0.000304	0.00226	CcSEcCtD
Perindopril—Erythema—Carmustine—melanoma	0.000304	0.00226	CcSEcCtD
Perindopril—Malnutrition—Carmustine—melanoma	0.000304	0.00226	CcSEcCtD
Perindopril—Cough—Bleomycin—melanoma	0.000304	0.00226	CcSEcCtD
Perindopril—Chills—Temozolomide—melanoma	0.000303	0.00225	CcSEcCtD
Perindopril—Ill-defined disorder—Dactinomycin—melanoma	0.000301	0.00224	CcSEcCtD
Perindopril—Anaemia—Dactinomycin—melanoma	0.0003	0.00224	CcSEcCtD
Perindopril—Vomiting—Vemurafenib—melanoma	0.000298	0.00222	CcSEcCtD
Perindopril—Alopecia—Temozolomide—melanoma	0.000298	0.00222	CcSEcCtD
Perindopril—Dry skin—Docetaxel—melanoma	0.000297	0.00221	CcSEcCtD
Perindopril—Chest pain—Bleomycin—melanoma	0.000296	0.00221	CcSEcCtD
Perindopril—Myalgia—Bleomycin—melanoma	0.000296	0.00221	CcSEcCtD
Perindopril—Abdominal pain upper—Docetaxel—melanoma	0.000296	0.00221	CcSEcCtD
Perindopril—Orthostatic hypotension—Docetaxel—melanoma	0.000296	0.00221	CcSEcCtD
Perindopril—Rash—Vemurafenib—melanoma	0.000296	0.0022	CcSEcCtD
Perindopril—Mental disorder—Temozolomide—melanoma	0.000296	0.0022	CcSEcCtD
Perindopril—Dermatitis—Vemurafenib—melanoma	0.000295	0.0022	CcSEcCtD
Perindopril—Back pain—Carmustine—melanoma	0.000294	0.00219	CcSEcCtD
Perindopril—Headache—Vemurafenib—melanoma	0.000294	0.00219	CcSEcCtD
Perindopril—Malnutrition—Temozolomide—melanoma	0.000294	0.00219	CcSEcCtD
Perindopril—Erythema—Temozolomide—melanoma	0.000294	0.00219	CcSEcCtD
Perindopril—Breast disorder—Docetaxel—melanoma	0.000293	0.00218	CcSEcCtD
Perindopril—Discomfort—Bleomycin—melanoma	0.000293	0.00218	CcSEcCtD
Perindopril—Malaise—Dactinomycin—melanoma	0.000293	0.00218	CcSEcCtD
Perindopril—Cramp muscle—Docetaxel—melanoma	0.000292	0.00218	CcSEcCtD
Perindopril—Leukopenia—Dactinomycin—melanoma	0.000291	0.00216	CcSEcCtD
Perindopril—Nasopharyngitis—Docetaxel—melanoma	0.00029	0.00216	CcSEcCtD
Perindopril—Dysgeusia—Temozolomide—melanoma	0.000288	0.00214	CcSEcCtD
Perindopril—Confusional state—Bleomycin—melanoma	0.000287	0.00213	CcSEcCtD
Perindopril—Tremor—Carmustine—melanoma	0.000285	0.00212	CcSEcCtD
Perindopril—Anaphylactic shock—Bleomycin—melanoma	0.000284	0.00212	CcSEcCtD
Perindopril—Oedema—Bleomycin—melanoma	0.000284	0.00212	CcSEcCtD
Perindopril—Back pain—Temozolomide—melanoma	0.000284	0.00212	CcSEcCtD
Perindopril—Anaemia—Carmustine—melanoma	0.000281	0.00209	CcSEcCtD
Perindopril—Agitation—Carmustine—melanoma	0.000279	0.00208	CcSEcCtD
Perindopril—Nausea—Vemurafenib—melanoma	0.000279	0.00207	CcSEcCtD
Perindopril—Thrombocytopenia—Bleomycin—melanoma	0.000278	0.00207	CcSEcCtD
Perindopril—Myalgia—Dactinomycin—melanoma	0.000276	0.00206	CcSEcCtD
Perindopril—Bronchospasm—Docetaxel—melanoma	0.000276	0.00205	CcSEcCtD
Perindopril—Tremor—Temozolomide—melanoma	0.000275	0.00205	CcSEcCtD
Perindopril—Discomfort—Dactinomycin—melanoma	0.000273	0.00203	CcSEcCtD
Perindopril—Angina pectoris—Docetaxel—melanoma	0.000273	0.00203	CcSEcCtD
Perindopril—Ill-defined disorder—Temozolomide—melanoma	0.000273	0.00203	CcSEcCtD
Perindopril—Leukopenia—Carmustine—melanoma	0.000272	0.00203	CcSEcCtD
Perindopril—Anaemia—Temozolomide—melanoma	0.000271	0.00202	CcSEcCtD
Perindopril—Anorexia—Bleomycin—melanoma	0.000271	0.00202	CcSEcCtD
Perindopril—Agitation—Temozolomide—melanoma	0.00027	0.00201	CcSEcCtD
Perindopril—Angioedema—Temozolomide—melanoma	0.000268	0.002	CcSEcCtD
Perindopril—Pancytopenia—Docetaxel—melanoma	0.000266	0.00198	CcSEcCtD
Perindopril—Hypotension—Bleomycin—melanoma	0.000266	0.00198	CcSEcCtD
Perindopril—Oedema—Dactinomycin—melanoma	0.000265	0.00197	CcSEcCtD
Perindopril—Malaise—Temozolomide—melanoma	0.000265	0.00197	CcSEcCtD
Perindopril—Vertigo—Temozolomide—melanoma	0.000264	0.00197	CcSEcCtD
Perindopril—Leukopenia—Temozolomide—melanoma	0.000263	0.00196	CcSEcCtD
Perindopril—Hypertension—Carmustine—melanoma	0.000262	0.00195	CcSEcCtD
Perindopril—Neutropenia—Docetaxel—melanoma	0.000262	0.00195	CcSEcCtD
Perindopril—Palpitations—Temozolomide—melanoma	0.00026	0.00193	CcSEcCtD
Perindopril—Thrombocytopenia—Dactinomycin—melanoma	0.000259	0.00193	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Bleomycin—melanoma	0.000259	0.00193	CcSEcCtD
Perindopril—Myalgia—Carmustine—melanoma	0.000259	0.00193	CcSEcCtD
Perindopril—Chest pain—Carmustine—melanoma	0.000259	0.00193	CcSEcCtD
Perindopril—Anxiety—Carmustine—melanoma	0.000258	0.00192	CcSEcCtD
Perindopril—Cough—Temozolomide—melanoma	0.000256	0.00191	CcSEcCtD
Perindopril—Paraesthesia—Bleomycin—melanoma	0.000255	0.0019	CcSEcCtD
Perindopril—Hypertension—Temozolomide—melanoma	0.000254	0.00189	CcSEcCtD
Perindopril—Dyspnoea—Bleomycin—melanoma	0.000253	0.00189	CcSEcCtD
Perindopril—Anorexia—Dactinomycin—melanoma	0.000253	0.00188	CcSEcCtD
Perindopril—Pneumonia—Docetaxel—melanoma	0.000251	0.00187	CcSEcCtD
Perindopril—Confusional state—Carmustine—melanoma	0.00025	0.00186	CcSEcCtD
Perindopril—Arthralgia—Temozolomide—melanoma	0.00025	0.00186	CcSEcCtD
Perindopril—Myalgia—Temozolomide—melanoma	0.00025	0.00186	CcSEcCtD
Perindopril—Anxiety—Temozolomide—melanoma	0.000249	0.00186	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000248	0.00185	CcSEcCtD
Perindopril—Oedema—Carmustine—melanoma	0.000248	0.00185	CcSEcCtD
Perindopril—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000248	0.00185	CcSEcCtD
Perindopril—Discomfort—Temozolomide—melanoma	0.000247	0.00184	CcSEcCtD
Perindopril—Decreased appetite—Bleomycin—melanoma	0.000247	0.00184	CcSEcCtD
Perindopril—Acute coronary syndrome—Docetaxel—melanoma	0.000246	0.00184	CcSEcCtD
Perindopril—Renal failure—Docetaxel—melanoma	0.000246	0.00183	CcSEcCtD
Perindopril—Myocardial infarction—Docetaxel—melanoma	0.000245	0.00182	CcSEcCtD
Perindopril—Dry mouth—Temozolomide—melanoma	0.000245	0.00182	CcSEcCtD
Perindopril—Jaundice—Docetaxel—melanoma	0.000244	0.00181	CcSEcCtD
Perindopril—Stomatitis—Docetaxel—melanoma	0.000244	0.00181	CcSEcCtD
Perindopril—Pain—Bleomycin—melanoma	0.000243	0.00181	CcSEcCtD
Perindopril—Conjunctivitis—Docetaxel—melanoma	0.000243	0.00181	CcSEcCtD
Perindopril—Thrombocytopenia—Carmustine—melanoma	0.000243	0.00181	CcSEcCtD
Perindopril—Tachycardia—Carmustine—melanoma	0.000242	0.0018	CcSEcCtD
Perindopril—Confusional state—Temozolomide—melanoma	0.000242	0.0018	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000241	0.0018	CcSEcCtD
Perindopril—Anaphylactic shock—Temozolomide—melanoma	0.00024	0.00179	CcSEcCtD
Perindopril—Oedema—Temozolomide—melanoma	0.00024	0.00179	CcSEcCtD
Perindopril—Anorexia—Carmustine—melanoma	0.000236	0.00176	CcSEcCtD
Perindopril—Hepatobiliary disease—Docetaxel—melanoma	0.000236	0.00176	CcSEcCtD
Perindopril—Epistaxis—Docetaxel—melanoma	0.000236	0.00176	CcSEcCtD
Perindopril—Nervous system disorder—Temozolomide—melanoma	0.000235	0.00175	CcSEcCtD
Perindopril—Thrombocytopenia—Temozolomide—melanoma	0.000235	0.00175	CcSEcCtD
Perindopril—Feeling abnormal—Bleomycin—melanoma	0.000234	0.00174	CcSEcCtD
Perindopril—Agranulocytosis—Docetaxel—melanoma	0.000233	0.00174	CcSEcCtD
Perindopril—Skin disorder—Temozolomide—melanoma	0.000233	0.00173	CcSEcCtD
Perindopril—Hypotension—Carmustine—melanoma	0.000232	0.00173	CcSEcCtD
Perindopril—Hyperhidrosis—Temozolomide—melanoma	0.000232	0.00173	CcSEcCtD
Perindopril—Decreased appetite—Dactinomycin—melanoma	0.00023	0.00172	CcSEcCtD
Perindopril—ABCB1—head—melanoma	0.000229	0.00671	CbGeAlD
Perindopril—Fatigue—Dactinomycin—melanoma	0.000229	0.0017	CcSEcCtD
Perindopril—Anorexia—Temozolomide—melanoma	0.000229	0.0017	CcSEcCtD
Perindopril—Cilazapril—ABCB1—melanoma	0.000227	0.0316	CrCbGaD
Perindopril—Pain—Dactinomycin—melanoma	0.000227	0.00169	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Carmustine—melanoma	0.000226	0.00168	CcSEcCtD
Perindopril—Urticaria—Bleomycin—melanoma	0.000226	0.00168	CcSEcCtD
Perindopril—Haemoglobin—Docetaxel—melanoma	0.000226	0.00168	CcSEcCtD
Perindopril—Rhinitis—Docetaxel—melanoma	0.000225	0.00168	CcSEcCtD
Perindopril—Body temperature increased—Bleomycin—melanoma	0.000225	0.00167	CcSEcCtD
Perindopril—Haemorrhage—Docetaxel—melanoma	0.000224	0.00167	CcSEcCtD
Perindopril—Hepatitis—Docetaxel—melanoma	0.000224	0.00167	CcSEcCtD
Perindopril—Insomnia—Carmustine—melanoma	0.000224	0.00167	CcSEcCtD
Perindopril—Paraesthesia—Carmustine—melanoma	0.000223	0.00166	CcSEcCtD
Perindopril—Pharyngitis—Docetaxel—melanoma	0.000223	0.00166	CcSEcCtD
Perindopril—Urinary tract disorder—Docetaxel—melanoma	0.000222	0.00165	CcSEcCtD
Perindopril—Dyspnoea—Carmustine—melanoma	0.000221	0.00165	CcSEcCtD
Perindopril—Oedema peripheral—Docetaxel—melanoma	0.000221	0.00165	CcSEcCtD
Perindopril—Somnolence—Carmustine—melanoma	0.000221	0.00164	CcSEcCtD
Perindopril—Urethral disorder—Docetaxel—melanoma	0.00022	0.00164	CcSEcCtD
Perindopril—Feeling abnormal—Dactinomycin—melanoma	0.000218	0.00163	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Temozolomide—melanoma	0.000218	0.00163	CcSEcCtD
Perindopril—Insomnia—Temozolomide—melanoma	0.000217	0.00161	CcSEcCtD
Perindopril—Gastrointestinal pain—Dactinomycin—melanoma	0.000217	0.00161	CcSEcCtD
Perindopril—Visual impairment—Docetaxel—melanoma	0.000216	0.00161	CcSEcCtD
Perindopril—Decreased appetite—Carmustine—melanoma	0.000216	0.00161	CcSEcCtD
Perindopril—Paraesthesia—Temozolomide—melanoma	0.000215	0.0016	CcSEcCtD
Perindopril—Gastrointestinal disorder—Carmustine—melanoma	0.000214	0.00159	CcSEcCtD
Perindopril—Dyspnoea—Temozolomide—melanoma	0.000214	0.00159	CcSEcCtD
Perindopril—Somnolence—Temozolomide—melanoma	0.000213	0.00159	CcSEcCtD
Perindopril—Erythema multiforme—Docetaxel—melanoma	0.000212	0.00158	CcSEcCtD
Perindopril—Pain—Carmustine—melanoma	0.000212	0.00158	CcSEcCtD
Perindopril—Constipation—Carmustine—melanoma	0.000212	0.00158	CcSEcCtD
Perindopril—Dyspepsia—Temozolomide—melanoma	0.000211	0.00157	CcSEcCtD
Perindopril—Eye disorder—Docetaxel—melanoma	0.00021	0.00156	CcSEcCtD
Perindopril—Abdominal pain—Dactinomycin—melanoma	0.00021	0.00156	CcSEcCtD
Perindopril—Body temperature increased—Dactinomycin—melanoma	0.00021	0.00156	CcSEcCtD
Perindopril—Decreased appetite—Temozolomide—melanoma	0.000208	0.00155	CcSEcCtD
Perindopril—Cardiac disorder—Docetaxel—melanoma	0.000208	0.00155	CcSEcCtD
Perindopril—Flushing—Docetaxel—melanoma	0.000208	0.00155	CcSEcCtD
Perindopril—Gastrointestinal disorder—Temozolomide—melanoma	0.000207	0.00154	CcSEcCtD
Perindopril—Fatigue—Temozolomide—melanoma	0.000207	0.00154	CcSEcCtD
Perindopril—Pain—Temozolomide—melanoma	0.000205	0.00153	CcSEcCtD
Perindopril—Constipation—Temozolomide—melanoma	0.000205	0.00153	CcSEcCtD
Perindopril—Feeling abnormal—Carmustine—melanoma	0.000204	0.00152	CcSEcCtD
Perindopril—Asthenia—Bleomycin—melanoma	0.000204	0.00152	CcSEcCtD
Perindopril—Angiopathy—Docetaxel—melanoma	0.000204	0.00152	CcSEcCtD
Perindopril—Gastrointestinal pain—Carmustine—melanoma	0.000203	0.00151	CcSEcCtD
Perindopril—Mediastinal disorder—Docetaxel—melanoma	0.000202	0.00151	CcSEcCtD
Perindopril—Chills—Docetaxel—melanoma	0.000201	0.0015	CcSEcCtD
Perindopril—Pruritus—Bleomycin—melanoma	0.000201	0.0015	CcSEcCtD
Perindopril—Arrhythmia—Docetaxel—melanoma	0.0002	0.00149	CcSEcCtD
Perindopril—Alopecia—Docetaxel—melanoma	0.000198	0.00148	CcSEcCtD
Perindopril—Feeling abnormal—Temozolomide—melanoma	0.000198	0.00147	CcSEcCtD
Perindopril—Mental disorder—Docetaxel—melanoma	0.000197	0.00146	CcSEcCtD
Perindopril—Abdominal pain—Carmustine—melanoma	0.000196	0.00146	CcSEcCtD
Perindopril—Body temperature increased—Carmustine—melanoma	0.000196	0.00146	CcSEcCtD
Perindopril—Gastrointestinal pain—Temozolomide—melanoma	0.000196	0.00146	CcSEcCtD
Perindopril—Malnutrition—Docetaxel—melanoma	0.000195	0.00145	CcSEcCtD
Perindopril—Erythema—Docetaxel—melanoma	0.000195	0.00145	CcSEcCtD
Perindopril—Dysgeusia—Docetaxel—melanoma	0.000191	0.00142	CcSEcCtD
Perindopril—Urticaria—Temozolomide—melanoma	0.00019	0.00142	CcSEcCtD
Perindopril—Asthenia—Dactinomycin—melanoma	0.00019	0.00142	CcSEcCtD
Perindopril—Body temperature increased—Temozolomide—melanoma	0.00019	0.00141	CcSEcCtD
Perindopril—Abdominal pain—Temozolomide—melanoma	0.00019	0.00141	CcSEcCtD
Perindopril—Back pain—Docetaxel—melanoma	0.000189	0.00141	CcSEcCtD
Perindopril—Muscle spasms—Docetaxel—melanoma	0.000188	0.0014	CcSEcCtD
Perindopril—Diarrhoea—Dactinomycin—melanoma	0.000181	0.00135	CcSEcCtD
Perindopril—Vomiting—Bleomycin—melanoma	0.000181	0.00135	CcSEcCtD
Perindopril—Anaemia—Docetaxel—melanoma	0.000181	0.00134	CcSEcCtD
Perindopril—Rash—Bleomycin—melanoma	0.000179	0.00133	CcSEcCtD
Perindopril—Dermatitis—Bleomycin—melanoma	0.000179	0.00133	CcSEcCtD
Perindopril—Asthenia—Carmustine—melanoma	0.000178	0.00133	CcSEcCtD
Perindopril—SLC15A2—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000177	0.00778	CbGpPWpGaD
Perindopril—Syncope—Docetaxel—melanoma	0.000175	0.0013	CcSEcCtD
Perindopril—Leukopenia—Docetaxel—melanoma	0.000175	0.0013	CcSEcCtD
Perindopril—Palpitations—Docetaxel—melanoma	0.000173	0.00129	CcSEcCtD
Perindopril—Asthenia—Temozolomide—melanoma	0.000172	0.00128	CcSEcCtD
Perindopril—Loss of consciousness—Docetaxel—melanoma	0.000172	0.00128	CcSEcCtD
Perindopril—ABCB1—Drug Induction of Bile Acid Pathway—VDR—melanoma	0.000171	0.00753	CbGpPWpGaD
Perindopril—Cough—Docetaxel—melanoma	0.00017	0.00127	CcSEcCtD
Perindopril—Diarrhoea—Carmustine—melanoma	0.00017	0.00126	CcSEcCtD
Perindopril—Pruritus—Temozolomide—melanoma	0.00017	0.00126	CcSEcCtD
Perindopril—Nausea—Bleomycin—melanoma	0.000169	0.00126	CcSEcCtD
Perindopril—Hypertension—Docetaxel—melanoma	0.000169	0.00126	CcSEcCtD
Perindopril—Vomiting—Dactinomycin—melanoma	0.000169	0.00126	CcSEcCtD
Perindopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	0.000168	0.00739	CbGpPWpGaD
Perindopril—Rash—Dactinomycin—melanoma	0.000167	0.00124	CcSEcCtD
Perindopril—Enalapril—ABCB1—melanoma	0.000167	0.0232	CrCbGaD
Perindopril—Arthralgia—Docetaxel—melanoma	0.000166	0.00124	CcSEcCtD
Perindopril—Chest pain—Docetaxel—melanoma	0.000166	0.00124	CcSEcCtD
Perindopril—Myalgia—Docetaxel—melanoma	0.000166	0.00124	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000165	0.00123	CcSEcCtD
Perindopril—SLC15A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000164	0.00722	CbGpPWpGaD
Perindopril—Dizziness—Carmustine—melanoma	0.000164	0.00122	CcSEcCtD
Perindopril—Diarrhoea—Temozolomide—melanoma	0.000164	0.00122	CcSEcCtD
Perindopril—Dry mouth—Docetaxel—melanoma	0.000163	0.00121	CcSEcCtD
Perindopril—Confusional state—Docetaxel—melanoma	0.000161	0.0012	CcSEcCtD
Perindopril—ABCB1—lymph node—melanoma	0.00016	0.0047	CbGeAlD
Perindopril—ACE—Peptide hormone metabolism—IGF1—melanoma	0.000159	0.00702	CbGpPWpGaD
Perindopril—Anaphylactic shock—Docetaxel—melanoma	0.000159	0.00119	CcSEcCtD
Perindopril—Oedema—Docetaxel—melanoma	0.000159	0.00119	CcSEcCtD
Perindopril—Dizziness—Temozolomide—melanoma	0.000159	0.00118	CcSEcCtD
Perindopril—Vomiting—Carmustine—melanoma	0.000158	0.00117	CcSEcCtD
Perindopril—Nausea—Dactinomycin—melanoma	0.000157	0.00117	CcSEcCtD
Perindopril—Shock—Docetaxel—melanoma	0.000157	0.00117	CcSEcCtD
Perindopril—Rash—Carmustine—melanoma	0.000156	0.00116	CcSEcCtD
Perindopril—Nervous system disorder—Docetaxel—melanoma	0.000156	0.00116	CcSEcCtD
Perindopril—Dermatitis—Carmustine—melanoma	0.000156	0.00116	CcSEcCtD
Perindopril—Thrombocytopenia—Docetaxel—melanoma	0.000156	0.00116	CcSEcCtD
Perindopril—Tachycardia—Docetaxel—melanoma	0.000156	0.00116	CcSEcCtD
Perindopril—Headache—Carmustine—melanoma	0.000155	0.00116	CcSEcCtD
Perindopril—Skin disorder—Docetaxel—melanoma	0.000155	0.00115	CcSEcCtD
Perindopril—Vomiting—Temozolomide—melanoma	0.000152	0.00114	CcSEcCtD
Perindopril—Anorexia—Docetaxel—melanoma	0.000152	0.00113	CcSEcCtD
Perindopril—Rash—Temozolomide—melanoma	0.000151	0.00113	CcSEcCtD
Perindopril—Dermatitis—Temozolomide—melanoma	0.000151	0.00112	CcSEcCtD
Perindopril—Headache—Temozolomide—melanoma	0.00015	0.00112	CcSEcCtD
Perindopril—Hypotension—Docetaxel—melanoma	0.000149	0.00111	CcSEcCtD
Perindopril—Nausea—Carmustine—melanoma	0.000147	0.0011	CcSEcCtD
Perindopril—BCHE—Phospholipid metabolism—GPAM—melanoma	0.000147	0.00648	CbGpPWpGaD
Perindopril—Musculoskeletal discomfort—Docetaxel—melanoma	0.000145	0.00108	CcSEcCtD
Perindopril—Insomnia—Docetaxel—melanoma	0.000144	0.00107	CcSEcCtD
Perindopril—ACE—Metabolism of proteins—SLC17A5—melanoma	0.000144	0.00634	CbGpPWpGaD
Perindopril—Paraesthesia—Docetaxel—melanoma	0.000143	0.00107	CcSEcCtD
Perindopril—Nausea—Temozolomide—melanoma	0.000142	0.00106	CcSEcCtD
Perindopril—Dyspnoea—Docetaxel—melanoma	0.000142	0.00106	CcSEcCtD
Perindopril—Somnolence—Docetaxel—melanoma	0.000142	0.00106	CcSEcCtD
Perindopril—BCHE—Peptide hormone metabolism—PAX6—melanoma	0.000141	0.00619	CbGpPWpGaD
Perindopril—Dyspepsia—Docetaxel—melanoma	0.00014	0.00105	CcSEcCtD
Perindopril—BCHE—Transmission across Chemical Synapses—SLC6A11—melanoma	0.00014	0.00617	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—ADAMTS13—melanoma	0.000139	0.00612	CbGpPWpGaD
Perindopril—Decreased appetite—Docetaxel—melanoma	0.000139	0.00103	CcSEcCtD
Perindopril—Gastrointestinal disorder—Docetaxel—melanoma	0.000138	0.00103	CcSEcCtD
Perindopril—Fatigue—Docetaxel—melanoma	0.000137	0.00102	CcSEcCtD
Perindopril—Constipation—Docetaxel—melanoma	0.000136	0.00102	CcSEcCtD
Perindopril—Pain—Docetaxel—melanoma	0.000136	0.00102	CcSEcCtD
Perindopril—SLC15A2—Transmembrane transport of small molecules—ARL2—melanoma	0.000136	0.00597	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—NDRG1—melanoma	0.000134	0.00589	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—MCL1—melanoma	0.000134	0.00589	CbGpPWpGaD
Perindopril—Feeling abnormal—Docetaxel—melanoma	0.000131	0.000978	CcSEcCtD
Perindopril—Gastrointestinal pain—Docetaxel—melanoma	0.00013	0.000971	CcSEcCtD
Perindopril—Body temperature increased—Docetaxel—melanoma	0.000126	0.000939	CcSEcCtD
Perindopril—Abdominal pain—Docetaxel—melanoma	0.000126	0.000939	CcSEcCtD
Perindopril—SLC15A1—Transmembrane transport of small molecules—ARL2—melanoma	0.000126	0.00554	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—PLA2G6—melanoma	0.000125	0.00551	CbGpPWpGaD
Perindopril—ACE—Peptide hormone metabolism—CTNNB1—melanoma	0.000118	0.00521	CbGpPWpGaD
Perindopril—Asthenia—Docetaxel—melanoma	0.000114	0.000852	CcSEcCtD
Perindopril—Pruritus—Docetaxel—melanoma	0.000113	0.00084	CcSEcCtD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—melanoma	0.000109	0.00482	CbGpPWpGaD
Perindopril—Diarrhoea—Docetaxel—melanoma	0.000109	0.000812	CcSEcCtD
Perindopril—BCHE—Neuronal System—SLC6A11—melanoma	0.000107	0.00473	CbGpPWpGaD
Perindopril—Dizziness—Docetaxel—melanoma	0.000105	0.000785	CcSEcCtD
Perindopril—ACE—Metabolism of proteins—RPS3—melanoma	0.000104	0.00456	CbGpPWpGaD
Perindopril—Vomiting—Docetaxel—melanoma	0.000101	0.000755	CcSEcCtD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—melanoma	0.000101	0.00445	CbGpPWpGaD
Perindopril—Rash—Docetaxel—melanoma	0.000101	0.000749	CcSEcCtD
Perindopril—Dermatitis—Docetaxel—melanoma	0.0001	0.000748	CcSEcCtD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.0001	0.00441	CbGpPWpGaD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB2—melanoma	0.0001	0.00441	CbGpPWpGaD
Perindopril—Headache—Docetaxel—melanoma	9.99e-05	0.000744	CcSEcCtD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—melanoma	9.97e-05	0.00439	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—SLC17A5—melanoma	9.89e-05	0.00435	CbGpPWpGaD
Perindopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	9.83e-05	0.00432	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—SLC15A2—melanoma	9.54e-05	0.0042	CbGpPWpGaD
Perindopril—Nausea—Docetaxel—melanoma	9.47e-05	0.000705	CcSEcCtD
Perindopril—SLC15A1—Transmembrane transport of small molecules—SLC17A5—melanoma	9.18e-05	0.00404	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—FOXP3—melanoma	9.1e-05	0.004	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—ETS1—melanoma	9.04e-05	0.00398	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—SLC6A11—melanoma	8.98e-05	0.00395	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—PIGU—melanoma	8.67e-05	0.00381	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—ADAMTS20—melanoma	8.67e-05	0.00381	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—GRIN2A—melanoma	8.57e-05	0.00377	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—SLC6A11—melanoma	8.34e-05	0.00367	CbGpPWpGaD
Perindopril—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—melanoma	8.08e-05	0.00356	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—EPO—melanoma	7.96e-05	0.0035	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—ARL2—melanoma	7.93e-05	0.00349	CbGpPWpGaD
Perindopril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	7.5e-05	0.0033	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—CXCR4—melanoma	7.42e-05	0.00326	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CAPN1—melanoma	7.1e-05	0.00312	CbGpPWpGaD
Perindopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	6.85e-05	0.00301	CbGpPWpGaD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—melanoma	6.83e-05	0.00301	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—PAX6—melanoma	6.61e-05	0.00291	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—GRIN2A—melanoma	6.56e-05	0.00289	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—IGF1—melanoma	6.4e-05	0.00282	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—HSPA5—melanoma	6.36e-05	0.0028	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CTLA4—melanoma	6.26e-05	0.00276	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—ABCB5—melanoma	6.14e-05	0.0027	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	6.08e-05	0.00267	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—SLC17A5—melanoma	5.78e-05	0.00254	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	5.72e-05	0.00252	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—EDN1—melanoma	5.69e-05	0.0025	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—ADAMTS13—melanoma	5.58e-05	0.00246	CbGpPWpGaD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—melanoma	5.3e-05	0.00233	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	5.1e-05	0.00224	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	5.1e-05	0.00224	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CUBN—melanoma	5.07e-05	0.00223	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CD86—melanoma	4.97e-05	0.00218	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—TERT—melanoma	4.96e-05	0.00218	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IL10—melanoma	4.87e-05	0.00214	CbGpPWpGaD
Perindopril—BCHE—Peptide hormone metabolism—CTNNB1—melanoma	4.75e-05	0.00209	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—PIK3CG—melanoma	4.74e-05	0.00209	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—GPAM—melanoma	4.74e-05	0.00209	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—HIF1A—melanoma	4.74e-05	0.00209	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IL4—melanoma	4.74e-05	0.00208	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—melanoma	4.71e-05	0.00207	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—PDGFRA—melanoma	4.66e-05	0.00205	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—HLA-B—melanoma	4.63e-05	0.00204	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	4.57e-05	0.00201	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—FASLG—melanoma	4.53e-05	0.00199	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—PRKCA—melanoma	4.5e-05	0.00198	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ACER3—melanoma	4.47e-05	0.00197	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—FAS—melanoma	4.37e-05	0.00192	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—melanoma	4.34e-05	0.00191	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—NOS2—melanoma	4.31e-05	0.0019	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—HLA-A—melanoma	4.29e-05	0.00189	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—ARL2—melanoma	4.26e-05	0.00187	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—PIK3CD—melanoma	4.17e-05	0.00183	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—RPS3—melanoma	4.16e-05	0.00183	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—SLC5A5—melanoma	4.11e-05	0.00181	CbGpPWpGaD
Perindopril—BCHE—Metabolism—UGT2B10—melanoma	4.08e-05	0.0018	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	4.03e-05	0.00177	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—HLA-DRB1—melanoma	3.92e-05	0.00173	CbGpPWpGaD
Perindopril—SLC15A2—SLC-mediated transmembrane transport—ALB—melanoma	3.86e-05	0.0017	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—melanoma	3.81e-05	0.00168	CbGpPWpGaD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	3.81e-05	0.00168	CbGpPWpGaD
Perindopril—BCHE—Metabolism—HS3ST5—melanoma	3.8e-05	0.00167	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—MMP1—melanoma	3.77e-05	0.00166	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—PIK3CB—melanoma	3.63e-05	0.0016	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CD80—melanoma	3.62e-05	0.00159	CbGpPWpGaD
Perindopril—SLC15A1—SLC-mediated transmembrane transport—ALB—melanoma	3.58e-05	0.00157	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—PRKCA—melanoma	3.45e-05	0.00152	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CASP8—melanoma	3.37e-05	0.00148	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—BRAF—melanoma	3.31e-05	0.00146	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	3.22e-05	0.00142	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—PTEN—melanoma	3.14e-05	0.00138	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—ABCB1—melanoma	3.13e-05	0.00138	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	3.1e-05	0.00137	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	3.06e-05	0.00134	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—IGF1—melanoma	3.01e-05	0.00132	CbGpPWpGaD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	2.92e-05	0.00128	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—MMP2—melanoma	2.91e-05	0.00128	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—ABCB1—melanoma	2.91e-05	0.00128	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PLCB4—melanoma	2.88e-05	0.00127	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IFNG—melanoma	2.86e-05	0.00126	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—FASN—melanoma	2.82e-05	0.00124	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	2.82e-05	0.00124	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—MDM2—melanoma	2.78e-05	0.00122	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIP4K2A—melanoma	2.71e-05	0.00119	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SLC6A11—melanoma	2.71e-05	0.00119	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CXCL8—melanoma	2.66e-05	0.00117	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—PAX6—melanoma	2.65e-05	0.00117	CbGpPWpGaD
Perindopril—BCHE—Metabolism—MTAP—melanoma	2.63e-05	0.00116	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.57e-05	0.00113	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—HSPA5—melanoma	2.55e-05	0.00112	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CASP3—melanoma	2.55e-05	0.00112	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IL2—melanoma	2.54e-05	0.00112	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—BRAF—melanoma	2.54e-05	0.00112	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	2.53e-05	0.00111	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	2.5e-05	0.0011	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—CXCL8—melanoma	2.42e-05	0.00107	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	2.38e-05	0.00105	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PHGDH—melanoma	2.35e-05	0.00103	CbGpPWpGaD
Perindopril—BCHE—Metabolism—LUM—melanoma	2.35e-05	0.00103	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	2.33e-05	0.00102	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	2.3e-05	0.00101	CbGpPWpGaD
Perindopril—BCHE—Metabolism—HPSE—melanoma	2.3e-05	0.00101	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	2.28e-05	0.001	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CUBN—melanoma	2.26e-05	0.000994	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	2.23e-05	0.000983	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—CTNNB1—melanoma	2.23e-05	0.000983	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—PIK3CA—melanoma	2.22e-05	0.000975	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	2.19e-05	0.000965	CbGpPWpGaD
Perindopril—BCHE—Metabolism—BSG—melanoma	2.18e-05	0.00096	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SDHD—melanoma	2.18e-05	0.00096	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CSPG4—melanoma	2.18e-05	0.00096	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ACER3—melanoma	2.18e-05	0.000959	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—VEGFA—melanoma	2.16e-05	0.000951	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	2.15e-05	0.000948	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—MDM2—melanoma	2.13e-05	0.000936	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GPAM—melanoma	2.11e-05	0.000929	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	2.11e-05	0.000929	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	2.01e-05	0.000882	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—UGT2B10—melanoma	1.99e-05	0.000877	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—ALB—melanoma	1.96e-05	0.000862	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	1.9e-05	0.000838	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—MAPK1—melanoma	1.9e-05	0.000835	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	1.9e-05	0.000834	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—TNF—melanoma	1.85e-05	0.000815	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—HS3ST5—melanoma	1.85e-05	0.000815	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—ALB—melanoma	1.82e-05	0.0008	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PLA2G6—melanoma	1.8e-05	0.00079	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	1.78e-05	0.000785	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	1.76e-05	0.000776	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	1.66e-05	0.000731	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	1.63e-05	0.000719	CbGpPWpGaD
Perindopril—BCHE—Metabolism—VCAN—melanoma	1.61e-05	0.00071	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	1.59e-05	0.000701	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	1.58e-05	0.000695	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.53e-05	0.000672	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—HRAS—melanoma	1.52e-05	0.00067	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—MMP1—melanoma	1.51e-05	0.000665	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	1.5e-05	0.000661	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.47e-05	0.000649	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—MAPK1—melanoma	1.45e-05	0.00064	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	1.43e-05	0.000627	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	1.41e-05	0.000618	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PLCB4—melanoma	1.4e-05	0.000618	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	1.39e-05	0.00061	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP17A1—melanoma	1.36e-05	0.000599	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	1.35e-05	0.000596	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.34e-05	0.000591	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—ALB—melanoma	1.33e-05	0.000583	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SLC6A11—melanoma	1.32e-05	0.000581	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIP4K2A—melanoma	1.32e-05	0.000581	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	1.29e-05	0.000567	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GNA11—melanoma	1.29e-05	0.000566	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—MTAP—melanoma	1.28e-05	0.000565	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	1.28e-05	0.000565	CbGpPWpGaD
Perindopril—BCHE—Metabolism—FASN—melanoma	1.26e-05	0.000553	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	1.26e-05	0.000553	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SLC5A5—melanoma	1.24e-05	0.000544	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	1.22e-05	0.000539	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	1.21e-05	0.000533	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—IGF1—melanoma	1.21e-05	0.000532	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GNAQ—melanoma	1.2e-05	0.000526	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CD44—melanoma	1.2e-05	0.000526	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	1.18e-05	0.000521	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	1.18e-05	0.00052	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	1.18e-05	0.000517	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.17e-05	0.000515	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—MMP2—melanoma	1.17e-05	0.000514	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—HRAS—melanoma	1.17e-05	0.000514	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.16e-05	0.00051	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CYP1B1—melanoma	1.15e-05	0.000504	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—LUM—melanoma	1.14e-05	0.000504	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PHGDH—melanoma	1.14e-05	0.000504	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—HPSE—melanoma	1.12e-05	0.000494	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CUBN—melanoma	1.1e-05	0.000485	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.07e-05	0.00047	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SDHD—melanoma	1.06e-05	0.000468	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CSPG4—melanoma	1.06e-05	0.000468	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—BSG—melanoma	1.06e-05	0.000468	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GPAM—melanoma	1.03e-05	0.000453	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.01e-05	0.000445	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.01e-05	0.000444	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	9.82e-06	0.000432	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—CXCL8—melanoma	9.72e-06	0.000428	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	9.61e-06	0.000423	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	9.6e-06	0.000423	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ABCB1—melanoma	9.44e-06	0.000415	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	9.15e-06	0.000402	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	9.07e-06	0.000399	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—CTNNB1—melanoma	8.96e-06	0.000394	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PLA2G6—melanoma	8.76e-06	0.000386	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PRKCA—melanoma	8.68e-06	0.000382	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ERCC2—melanoma	8.61e-06	0.000379	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	8.34e-06	0.000367	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	8.06e-06	0.000355	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—VCAN—melanoma	7.87e-06	0.000346	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.13e-06	0.000314	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	6.81e-06	0.0003	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIK3CG—melanoma	6.8e-06	0.000299	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP17A1—melanoma	6.64e-06	0.000292	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PPARG—melanoma	6.56e-06	0.000289	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GNA11—melanoma	6.27e-06	0.000276	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	6.15e-06	0.000271	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—FASN—melanoma	6.14e-06	0.00027	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SLC5A5—melanoma	6.04e-06	0.000266	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIK3CD—melanoma	5.98e-06	0.000263	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ALB—melanoma	5.9e-06	0.00026	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GNAQ—melanoma	5.83e-06	0.000257	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CD44—melanoma	5.83e-06	0.000257	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYP1B1—melanoma	5.59e-06	0.000246	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIK3CB—melanoma	5.21e-06	0.000229	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PTGS2—melanoma	5.16e-06	0.000227	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PTEN—melanoma	4.5e-06	0.000198	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PRKCA—melanoma	4.24e-06	0.000186	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ERCC2—melanoma	4.2e-06	0.000185	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIK3CG—melanoma	3.32e-06	0.000146	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PPARG—melanoma	3.2e-06	0.000141	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIK3CA—melanoma	3.18e-06	0.00014	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIK3CD—melanoma	2.92e-06	0.000128	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ALB—melanoma	2.88e-06	0.000127	CbGpPWpGaD
Perindopril—BCHE—Metabolism—AKT1—melanoma	2.6e-06	0.000114	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIK3CB—melanoma	2.54e-06	0.000112	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PTGS2—melanoma	2.52e-06	0.000111	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PTEN—melanoma	2.2e-06	9.67e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIK3CA—melanoma	1.55e-06	6.82e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—AKT1—melanoma	1.27e-06	5.57e-05	CbGpPWpGaD
